Showing results (161-170 of 2,407) with videos related to
Sort By:
Pageof 241
Cancer Chemotherapy and Pharmacology|January 1, 1989
Tallysomycin S10b--a phase I trialP G Sørensen, H Pedersen, H V Clausen, et al.Acta Neurologica Scandinavica|May 1, 1994
Comparison of clinical neurological function and CT response during chemotherapy for initial brain metastases from small cell lung cancerP S Sørensen, P E Kristjansen, A Wagner, et al.Cancer Treatment Reports|March 1, 1979
Phase I trial of a new form of an oral administration of VP-16-213M E Lau, H H Hansen, N I Nissen, et al.British Journal of Cancer|December 1, 1988
The prognostic influence of serum neuron specific enolase in small cell lung cancerL G Jørgensen, K Osterlind, H H Hansen, et al.British Journal of Pharmacology|November 13, 2001
Effects of cannabinoids on adrenaline release from adrenal medullary cellsN Niederhoffer, H H Hansen, J J Fernandez-Ruiz, et al.Clinical Endocrinology|December 1, 1986
Calcitonin gene-related peptide and calcitonin in medullary thyroid carcinomaS Schifter, E D Williams, R K Craig, et al.British Journal of Cancer|September 1, 1992
Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC)L G Jørgensen, K Osterlind, H H Hansen, et al.Journal of Neurochemistry|July 19, 2000
Determination of the phospholipid precursor of anandamide and other N-acylethanolamine phospholipids before and after sodium azide-induced toxicity in cultured neocortical neuronsH H Hansen, S H Hansen, A Schousboe, et al.Journal of Mass Spectrometry : JMS|July 17, 1999
Electrospray ionization mass spectrometric method for the determination of cannabinoid precursors: N-acylethanolamine phospholipids (NAPEs)H H Hansen, S H Hansen, I Bjørnsdottir, et al.Cancer Treatment Reports|January 1, 1981
5-FU in the treatment of small cell anaplastic carcinoma of the lung: a phase II trialH Havsteen, S Sörenson, M Rørth, et al.Pageof 241